MedPath

SANDOZ TACROLIMUS XR

SANDOZ TACROLIMUS XR

Approved
DIN Number

02528606

Drug Class

Human

Market Date

N/A

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02528606
AIG Number0127857002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AD02 TACROLIMUS
Product Specifications
Dosage FormCapsule (Extended Release)
Route of AdministrationOral
AHFS Classification90:28.28.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

TACROLIMUSActive
Strength: 1 MG
Monograph: TACROLIMUS

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.